We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Proteins and Peptides in Tears Indicate Eye Conditions

By LabMedica International staff writers
Posted on 30 Apr 2013
Diseases such as dry eye and blepharitis (inflammation of the eyelids) change the proportions of certain proteins in normal tears.

A new test to diagnose dry eye would be especially useful because it is currently diagnosed by interview backed up by tests, which are not particularly reproducible.

Tatiana Suarez from Bioftalmik (Derio, Spain) and colleagues in Spain undertook a proteomics study using 2D PAGE to identify any potential protein biomarkers before carrying out a detailed validation study of the candidate species.

One hundred and forty-four participants were enrolled in the study, comprising 63 with dry eye, 38 with MGD and 43 healthy controls. More...
Tears were collected from 44 patients using surgical sponges, 16 with each disease, and 12 controls. The abundant protein immunoglobulin A was removed by immunoaffinity chromatography in case it swamped the less abundant proteins.

The remaining proteins were separated by 2D electrophoresis (PAGE) and their positions on the gel were identified by staining with a fluorescent dye. A total of 130 protein spots were resolved and image analysis was conducted to pinpoint the proteins which had different abundances between the three groups and these were identified by mass spectrometry.

Before refining the panel of proteins to a more manageable number that retained the predictive capability, they were screened by enzyme-linked immuno sorbent assay (ELISA) to identify the most predictive ones. Two validations steps followed in which the proteins were collected by sponge or capillary. The best classification method was achieved with the Random Forest and Naïve Bayes machine learning techniques which were trained using one set of results and confirmed on the others.

A network analysis of the 15 discriminatory proteins revealed that nine of them were directly or indirectly related. The major biological processes in which they are involved include inflammatory response, stress response, immune response, and oxidative stress response.

The final discriminatory panel obtained after refinement of the model consisted of five proteins: S100A6, annexin A1, annexin A11, cystatin-S and phospholipase A2-activating protein. Together they were able to discriminate between dry eye and control patients with high sensitivity and specificity. They could also distinguish between the dry eye, MGD, and control groups with good accuracy. The results were independent of the tear collection method.

The team will examine the biomarkers in a clinical setting and possibly develop a test for dry eye and meibomian gland dysfunction.

Related Links:
Bioftalmik




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Electrolyte Analyzer
BKE-B
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Ebola remains a rapidly evolving public health threat with high mortality, underscoring the need for timely diagnosis and decentralized testing closer to patients (Image Credit: Adobe Stock)

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) and ReadyGo Diagnostics Ltd. (Bath, UK) have initiated a collaboration to evaluate ReadyGo’s GoCollect with the Co-Dx PCR platform for blood-based molecular... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.